Semler Scientific Files 8-K on Financials and Operations
| Field | Detail |
|---|---|
| Company | Semler Scientific, Inc. |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | medium |
| Pages | 11 |
| Reading Time | 13 min |
| Key Dollar Amounts | $0.001, $6.9, $7.5 million, $12.8, $13.4 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, regulation-fd
Related Tickers: SMLR
TL;DR
SEMLER SCIENTIFIC (SMLR) FILED AN 8-K ON OCT 3RD - CHECK FOR FINANCIAL UPDATES.
AI Summary
Semler Scientific, Inc. filed an 8-K on October 3, 2025, reporting on Results of Operations and Financial Condition, Regulation FD Disclosure, and Other Events. The filing details the company's operational and financial status, along with any relevant disclosures or significant occurrences.
Why It Matters
This 8-K filing provides investors with crucial, up-to-date information on Semler Scientific's financial health and operational developments, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant news that may impact stock price, requiring careful investor attention.
Key Players & Entities
- Semler Scientific, Inc. (company) — Registrant
- October 3, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 001-36305 (identifier) — SEC File Number
- 26-1367393 (identifier) — IRS Employer Identification No.
- 51 E Campbell Ave , Suite 107-D Campbell , CA 95008 (address) — Principal Executive Offices
FAQ
What specific financial results or conditions are being reported in this 8-K?
The filing indicates 'Results of Operations and Financial Condition' are being reported, but specific details are not provided in the header information.
Are there any material events or disclosures being made under Regulation FD?
Yes, the filing explicitly lists 'Regulation FD Disclosure' as an item being reported.
What other significant events are being reported by Semler Scientific?
The filing also includes 'Other Events' as a reported item.
When was this 8-K filing submitted to the SEC?
The filing was submitted on October 3, 2025.
Where is Semler Scientific, Inc. headquartered?
The company's principal executive offices are located at 51 E Campbell Ave, Suite 107-D, Campbell, CA 95008.
Filing Stats: 3,211 words · 13 min read · ~11 pages · Grade level 15.2 · Accepted 2025-10-03 16:18:26
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SMLR The Nasdaq
- $6.9 — as of September 30, 2025: Revenues of $6.9 to $7.5 million. Operating expenses of
- $7.5 million — eptember 30, 2025: Revenues of $6.9 to $7.5 million. Operating expenses of $12.8 to $13.4
- $12.8 — to $7.5 million. Operating expenses of $12.8 to $13.4 million (which includes approx
- $13.4 million — illion. Operating expenses of $12.8 to $13.4 million (which includes approximately $2.1 mill
- $2.1 million — 4 million (which includes approximately $2.1 million of non-cash stock compensation and depr
- $30.0 million — gs since June 30, 2025 of approximately $30.0 million. Bitcoin holdings of 5,048 Bitcoins.
- $10.3 million — h and cash equivalents of approximately $10.3 million. Basic shares outstanding 15,142,195 a
- $500.0 million — issue and sell from time to time up to $500.0 million of its common stock in an at-the-market
- $203.8 million — aggregate net proceeds of approximately $203.8 million under this sales agreement. Total basic
- $3.1 million — ler Scientific acquired 27 Bitcoins for $3.1 million with an average purchase price of $114,
- $114,119 — llion with an average purchase price of $114,119 per Bitcoin, inclusive of fees and expe
- $479.0 million — which were acquired for an aggregate of $479.0 million at an average purchase price of $94,877
- $94,877 — million at an average purchase price of $94,877 per Bitcoin, inclusive of fees and expe
- $575.8 million — and expenses, and had a market value of $575.8 million based on the price of Bitcoin as report
Filing Documents
- smlr-20251003x8k.htm (8-K) — 68KB
- 0001554859-25-000053.txt ( ) — 186KB
- smlr-20251003.xsd (EX-101.SCH) — 3KB
- smlr-20251003_lab.xml (EX-101.LAB) — 16KB
- smlr-20251003_pre.xml (EX-101.PRE) — 10KB
- smlr-20251003x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. Although it has not yet finalized its full financial results for the third quarter ended September 30, 2025, Semler Scientific, Inc., or Semler Scientific, is providing select preliminary unaudited financial information for the third quarter ended September 30, 2025. Semler Scientific anticipates reporting for the three months ended and as of September 30, 2025: Revenues of $6.9 to $7.5 million. Operating expenses of $12.8 to $13.4 million (which includes approximately $2.1 million of non-cash stock compensation and depreciation and $2.1 million of non-recurring merger related consulting and professional fees). Unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025 of approximately $30.0 million. Bitcoin holdings of 5,048 Bitcoins. Cash, restricted cash and cash equivalents of approximately $10.3 million. Basic shares outstanding 15,142,195 and assumed diluted shares outstanding 17,296,094. Semler Scientific's financial closing procedures for the third quarter ended September 30, 2025, are not yet complete. The preliminary unaudited financial information presented are estimates based on information available to management as of the date of this current report on Form 8-K, have not been reviewed or audited by Semler Scientific's independent registered accounting firm, and are subject to change. It is possible that the final results may differ from the preliminary unaudited information provided, including differences due to the completion of the financial closing procedures and/or the interim review process; changes in facts, circumstances and/or assumptions and/or developments in the interim. The preliminary unaudited financial information does not present all information necessary for a complete understanding of Semler Scientific's results for the third quarter ended September 30, 2025 and should not be viewed as a substitute for full financial statements prepared in a
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Bitcoin Dashboard Semler Scientific maintains a dashboard on its website, www.semlerscientific.com, as a disclosure channel to provide broad, non-exclusionary distribution of information regarding Semler Scientific's Bitcoin holdings to the public. Some of the information distributed through the website dashboard may be considered material information. Semler Scientific intends to use this website dashboard as a means of complying with its disclosure obligations under Regulation FD. The website dashboard will include information regarding market data for Semler Scientific's common stock and Bitcoin, BTC Yield, BTC Gain and BTC $ Gain key performance indicators, or KPIs, Bitcoin purchases, Bitcoin holdings, and other related information. Investors and others are encouraged to regularly review the information that Semler Scientific makes public via the website dashboard. Furnished Information The information contained in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, or the Securities Act, except as shall be expressly set forth by specific reference in such filing.
01. Other Information
Item 8.01. Other Information. Select Preliminary Unaudited Financial Information The select preliminary unaudited financial information and Bitcoin holdings for the third quarter ended September 30, 2025 reported under Item 2.02 is hereby incorporated by reference herein. Semler Scientific's financial closing procedures for the third quarter ended September 30, 2025, are not yet complete. The preliminary unaudited financial information presented are estimates based on information available to management as of the date of this current report on Form 8-K, have not been reviewed or audited by Semler Scientific's independent registered accounting firm, and are subject to change. It is possible that the final results may differ from the preliminary unaudited information provided, including differences due to the completion of the financial closing procedures and/or the interim review process; changes in facts, circumstances and/or assumptions and/or developments in the interim. The preliminary unaudited financial information does not present all information necessary for a complete understanding of Semler Scientific's results for the third quarter ended September 30, 2025 and should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. Business Operations Update; Revenue Guidance Semler Scientific previously reported that it is experiencing and expects to continue to experience decreased usage of its QuantaFlo device due to the 2024 Medicare Advantage and Part D Final Rate Announcement issued by the Centers for Medicare and Medicaid Services, or CMS. While revenues have been gradually decreasing period over period in light of the CMS reimbursement landscape, a customer who represented more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of its QuantaFlo devices. In light of this development, Semler Scientific now currently anticipates fourth quarter 2025 revenues will be at least 60% lowe
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SEMLER SCIENTIFIC, INC. Date: October 3, 2025 By: /s/ Renae Cormier Name: Renae Cormier Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)